CL
SRPT icon

CSS LLC’s Sarepta Therapeutics SRPT Stock Holding History

CSS LLC’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,000
Closed -$2.12M – 947
2023
Q4 		$2.12M Buy
+22,000
New +$2.11M 0.12% 138
2023
Q1 		– Sell
-29,100
Closed -$3.77M – 887
2022
Q4 		$3.77M Hold
29,100
– – 0.21% 99
2022
Q3 		$3.22M Buy
+29,100
New +$2.93M 0.15% 153
2021
Q2 		– Sell
-3,100
Closed -$230K – 1168
2021
Q1 		$230K Sell
3,100
-19,600
-86% -$1.81M 0.01% 737
2020
Q4 		$3.87M Sell
22,700
-2,000
-8% -$296K 0.15% 115
2020
Q3 		$3.47M Sell
24,700
-7,300
-23% -$1.11M 0.16% 126
2020
Q2 		$5.13M Buy
32,000
+25,900
+425% +$3.52M 0.29% 87
2020
Q1 		$598K Sell
6,100
-35,100
-85% -$4.01M 0.05% 268
2019
Q4 		$5.32M Buy
41,200
+17,300
+72% +$1.75M 0.29% 78
2019
Q3 		$1.8M Buy
23,900
+16,500
+223% +$1.95M 0.12% 148
2019
Q2 		$1.12M Sell
7,400
-7,700
-51% -$936K 0.06% 197
2019
Q1 		$1.8M Buy
+15,100
New +$1.94M 0.11% 138

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CSS LLC's SRPT Position: Q3 2023 in Review

CSS LLC sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 6,700 shares — an estimated $767K sold.

CSS LLC first reported a position in SRPT in Q1 2020 and held it in 5 quarters. The position peaked at $767K in Q2 2023. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • CSS LLC reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • CSS LLC sold 6,700 Sarepta Therapeutics shares in Q3 2023, an estimated $767K.
  • CSS LLC first reported a position in Sarepta Therapeutics in Q1 2020 and held it in 5 quarters.
  • CSS LLC's Sarepta Therapeutics position peaked at $767K in Q2 2023.
  • 394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on CSS LLC's 13F filing for Q3 2023, filed 14 Nov 2023.